Aug 14, 2017 Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business

Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive

Sincerely, /s/ Uli Hacksell . Uli Hacksell, PhD. CEO & President. Cerecor Inc. 400 East Pratt Street, Suite 606. Baltimore, MD 21202 Uli Hacksell. Född: 1950 Titel: Koncernchef och VD Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.

Uli hacksell cerecor

Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public The chief executive of Baltimore-based Cerecor Inc. received a compensation package in 2016 worth 60 percent more than his predecessor’s compensation package in 2015, according to a filing with the Securities and Exchange Commission.. Dr. Uli Hacksell’s total compensation package for 2016 was valued at $1.7 million, compared to the $1.1 million package received by Cerecor’s former Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the Board of Directo Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell. As quoted in the press release: John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Currently, Uli Hacksell is the CEO of Cerecor, the former chief executive officer of Acadia Pharmaceuticals (NASDAQ:ACAD).Uli joined Cerecor in January of 2016. Uli Hacksell, Ph.D. Dr. Hacksell, age 68, has served on our Board since May 2015 and he was our President and Chief Executive Officer from January 2016 to August 2017.

Uli Hacksell, Ph.D. Dr. Hacksell, age 68, has served on our Board since May 2015 and he was our President and Chief Executive Officer from January 2016 to August 2017.

Baltimore, MD 21202 Uli Hacksell. Född: 1950 Titel: Koncernchef och VD Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016.

At Cerecor, he completed the acquisition of Ichorion Therapeutics, Inc., the purchase of Aevi Genomic Medicine, and facilitated a strategic transformation of the organization by leading the divestiture of the company’s commercial portfolio in a transaction with Aytu BioScience, Inc. in 2019.

President and Chief Executive Officer. Cerecor Inc. 400 E. Pratt Street. Suite 606.

Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell. As quoted in the press release: John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim 2016-05-20 · Uli Hacksell.
Sök jobb gnesta

Mariam Morris. 1st. Uli Hacksell.

See the complete profile on LinkedIn and discover Uli’s connections Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $59.4 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,400 and over the last 17 years Uli sold CERC stock worth over $0. 2018-06-29 · Dr. Hacksell, age 67, has served as Chairman of the Board of Directors of Cerecor Inc. since May 2015 and as President and Chief Executive Officer of Cerecor Inc. from January 2016 to August 2017.
Vaglangd rott ljus

bästa ögonkliniken stockholm
lekpedagogiskt arbetssätt
stefan salvatore
inredningskonsult göteborg
carrier careers canada
okq8 pris diesel
maria persson lund university

Lecturer: Margareta Hammarlund-Udenaes, Faculty of Pharmacy; Uli Hacksell, Cerecor Inc., USA; Jens Juul Holst, Department of Biomedical

Dr. Cerecor's president and chief executive Uli Hacksell announced his immediate retirement from those roles, saying that with the new $45 million deal and recent $5 million fundraising, "I can be Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016..

Restaurang sormland
sms schoolsoft aneby

At Cerecor, he completed the acquisition of Ichorion Therapeutics, Inc., the purchase of Aevi Genomic Medicine, and facilitated a strategic transformation of the organization by leading the divestiture of the company’s commercial portfolio in a transaction with Aytu BioScience, Inc. in 2019.

Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor Dr. Hacksell is replacing Sol Barer, PhD, who stepped down as the Chairman and as a member of Cerecor’s board of directors in April 2015. “We sincerely thank Sol for his contributions to Cerecor throughout his time serving as our Chairman,” said Dr. Paterson. Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders.

Professor Uli Hacksell, styrelseledamot, bidrar med forsknings- och Uli Hacksell sitter i styrelsen för Cerecor, där han också är VD, samt för

Uli Bengt Westermark samt nyval av två ledamöter, Uli Hacksell och Lennart Hansson.

CEO. Dr. Hacksell has served as Chairman of the Board of Directors of Adhera Therapeutics since July 2018. Dr. Hacksell has served as Chairman 20 okt 2020 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor, 09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO Board of directors · Dr. Wenche Rolfsen Marlene Forsell Prof.